Journal of Pediatric and Adolescent Gynecology
Volume 23, Issue 6 , Pages 364-367 , December 2010

Implanon: The Subdermal Contraceptive Implant

  • Michelle Isley, MD, MPH

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Michelle Isley, MD, MPH, 395 W 12th Avenue # 503, Department of Obstetrics and Gynecology, Columbus, OH 43210

References 

  1. Croxatto HB, Urbancsek J, Massai R, et al. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. Hum Reprod. 1999;14:976
  2. Funk S, Miller MM, Mishell DR, et al. Safety and efficacy of Implanon, a single- rod implantable contraceptive containing etonogestrel. Contraception. 2005;71:319
  3. Makarainen L, van Beek A, Tuomivaara L, et al. Ovarian function during the use of a single rod contraceptive implant: Implanon compared with Norplant. Fertil Steril. 1998;69:714
  4. Westerway SC, Picker R, Christie J. Implanon implant detection with ultrasound and magnetic resonance imaging. Aust N Z J Obstet Gynaecol. 2003;43:346
  5. Diaz S, Pavez M, Moo-Young A, et al. Clinical trial with 3-keto-desogestrel subdermal implants. Contraception. 1991;44:393
  6. Wenzel R, van Beek A, Schnabel P, et al. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon. Contraception. 1998;58:283
  7. Meckstroth K, Darney P. Implant contraception. Semin Reprod Med. 2001;19:339
  8. Huber J, Wenzl R. Pharmacokinetics of Implanon: an integrated analysis. Contraception. 1998;58(6 Suppl):85S
  9. Herjan JT. Coelingh-Bennink: Introduction-presentation of clinical data on Implanon. Contraception. 1998;58:75S–77S
  10. Harrison-Woodrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception. 2005;71:306
  11. Cherry S. Implanon. The new alternative. Aust Fam Physician. 2002;31:897–900
  12. Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon. Contraception. 1998;58(6 Suppl):99S
  13. Darney P, Patel A, Rosen K, et al. Safety and efficacy of a single rod etonogestrel implant (Implanon):results from 11 international clinical trials. Fertil Steril. 2009;91:1646
  14. Edwards JE, Moore A. Implanon: A review of clinical studies. Br J Fam Plann. 1999;24:3
  15. Urbancsek J. An integrated analysis of non-menstrual events with Implanon. Contraception. 1998;58(6 Suppl):109S
  16. Berenson AB, Wiemann CM, Rickerr VI, et al. Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use. Am J Obstet Gynecol. 1997;176:586
  17. Bitzer J, Tschudin S, Alder J, et al. Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group. Eur J Contracept Reprod Health Care. 2004;9:278
  18. Glasier A. Implantable contraceptives for women: effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies. Contraception. 2002;65:29
  19. Rai K, Gupta S, Cotter S, et al. Experience with Implanon in a northeast London family planning clinic. Eur J Contracept Reprod Health Care. 2004;9:39
  20. Reinprayoon D, Taneepanichskul S, Bunyavejchevin S, et al. Effects of the etonogestrel- releasing contraceptive implant (Implanon) on parameters of breastfeeding compared to those of an intrauterine device. Contraception. 2000;62:239
  21. Dorflinger LJ. Metabolic effects of implantable steroid contraceptives for women. Contraception. 2002;65:47
  22. Beerthuizen R, van Beek A, Massai R, et al. Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception. Hum Reprod. 2000;15:118
  23. Le J, Tsourounis C. Implanon: a critical review. Ann Pharmacother. 2001;35:329

PII: S1083-3188(10)00123-3

doi: 10.1016/j.jpag.2010.03.006

Journal of Pediatric and Adolescent Gynecology
Volume 23, Issue 6 , Pages 364-367 , December 2010

Article Tools